Verificar estado da encomenda

Faça parte de uma comunidade de amantes de livros de todo o mundo e tenha acesso a uma série de benefícios. Crie uma conta gratuitamente

Correio DHL 7.99 € Correio DPD 4.49 € Ponto DPD 3.99 € Correio GLS 5.49 € Correio MRW 5.49 € Ponto GLS 4.49 €

Contacto

Como comprar

Ajuda

A minha conta

▸ Vazio :-(

Ribavirin

Name: Ribavirin
Brand: Nova Science Publishers Inc
SKU: 06438636
Price: 123.4 EUR
Availability: InStock
Author: Joris Buskirk
ISBN: 9781628088137

Biochemistry, Clinical Applications & Potential Side Effects

Joris Buskirk

Língua

Inglês

Livro Capa mole

Código Libristo: 06438636

Editoras Nova Science Publishers Inc, dezembro 2013

Ribavirin has been studied for over 20 years as a potential therapy against a number of RNA and DNA... Descrição completa

Código Libristo: 06438636

299 b

123.40 €

50% de hipóteses Procuremos no mundo Quando vou receber o meu livro?

Até 30 dias para devoluções

Os clientes também compraram

P.I.C. Pisman Insanlar Cemiyeti Aytek Teoman

Capa mole

7.78 €

Die Zukunft der kantonalen Salzregale im europäischen Umfeld Bruno Hensler

Capa mole

59.98 €

Killing Stalking T05 Koogi

Capa mole

9.80 €

Curso de Derecho Diplomático y Consular EDUARDO VILARIÑO PINTOS

Capa mole

48.85 €

Die Straße von Cormac McCarthy (Lektürehilfe) Marie-Sophie Wauquez

Capa mole

14.35 €

LA LEÇON DU MAL A (VO JAPONAIS) KISHI

Capa mole

19.11 €

Ribavirin has been studied for over 20 years as a potential therapy against a number of RNA and DNA viruses. It is well known that Ribavirin in combination with Interferon is a key antiviral component in the treatment of Hepatitis C virus infection. In this book, the authors discuss the biochemistry, clinical applications and potential side effects of Ribavirin. Topics include optimising Ribavirin use for the treatment of Hepatitis C; Ribavirin and its great potential in infectious diseases; the antiviral actions of Ribavirin; a novel prediction method for the responsiveness of Hepatitis C patients to drug treatment; and Ribavirin''s intolerable cough during HCV combination therapy which can be overcome by replacement with Nitazoxanide.